Thus, we recommended VP as the drug of the first choice for luteal support in patients undergoing
IVF-ET with GnRH-antagonist protocol in young women.
(2003), the leading topics were
IVF-ET, infertility, endometriosis, pregnancy, ICSI, and fertility.15 Infertile individuals search similar topics on the Internet.
Keywords: Doppler ultrasound, Follicular phase,
IVF-ET, Pregnancy outcomes, Uterine artery.
136 nonpregnant patients among 259 patients in the IVF cycle began to take pentanoic acid estradiol orally at the third day of menstrual period after
IVF-ET treatment for 3 months or above.
However, the clinical use of GIFT and related techniques is becoming extremely rare due to drastic improvements in implantation rates associated with
IVF-ET.
* Eight hundred ninety-six age-matched patients with none of the described lesions who also underwent fresh
IVF-ET during the same time period.
In women undergoing in vitro fertilization and embryo transfer (
IVF-ET), serial measurements of 17[beta]-estradiol ([E.sub.2]) can be used to monitor follicular growth, and serum
[9.] See, for example, Medical Research International, "In Vitro Fertilization-Embryo Transfer (
IVF-ET) in the United States: 1989 Results from the
IVF-ET Registry," Fertility and Sterility 55, no.
The first baby conceived by
IVF-ET was born in 1978.
Her current pregnancy was conceived after in vitro fertilization and embryo transfer (
IVF-ET) following gonadotrophin-releasing hormone antagonist treatment for endometriosis.
We present a rare case of a 23-year-old woman with a twin pregnancy following in vitro fertilization-embryo transfer (
IVF-ET) who presented with symptoms of intestinal obstruction at 22+4 weeks of gestation.
A case of twin pregnancy with complete hydatidiform mole and coexisting fetus following
IVF-ET. J Assist Reprod Genet 2002;19(3):144-8.